Drug intelligence / Profile preview

recombinant PEX5 protein

Development stage
Preclinical
Lead developer
Wonkwang University Hospital
Modality
Recombinant Proteins and Enzymes
01

Overview

Recombinant PEX5 protein (rpPEX5) is a recombinant form of the peroxisomal biogenesis factor 5 (PEX5), which acts as a cytosolic receptor for peroxisomal matrix protein import. Beyond its established intracellular role in peroxisomal protein trafficking, extracellular recombinant PEX5 has been shown to act as a negative regulator of osteoclastogenesis. It inhibits receptor activator of nuclear factor kappa-B ligand (RANKL)-induced osteoclast differentiation and bone resorption by downregulating NFATc1 and dampening RANKL-mediated signaling pathways (including Akt, MAPK, IκB, and calcium-dependent pathways). In preclinical models, administration of recombinant PEX5 protein mitigates lipopolysaccharide (LPS)-induced inflammatory calvarial bone destruction, suggesting potential therapeutic utility in osteolytic diseases.

Other names
recombinant peroxin-5recombinant peroxisomal biogenesis factor 5recombinant peroxisomal targeting signal 1 receptorrecombinant Pex5recombinant PTS1 receptorrpPEX5rpPEX-5rpPEX 5

Beyond the preview

Go deeper on recombinant PEX5 protein.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on recombinant PEX5 protein.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call